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The effect of various  sulfhydryl  (SH)-specific reagents on arginine-ornithine  antiport  activity  in membrane  vesicles of 
Lactococcus lactis was studied. Little or no inhibition of arginine-ornithine  exchange was observed with maleimides and 
arsenicals.  HgC! 2 and the organic mercurials  p-chloromercuribenzene sulfonate (pCMBS),  p-chloromercuribenzoate 
(pCMB),  and  O-(3-hydroxymercuri-2-methoxypropyl)carbamylphenoxyacetate  completely  inactivated  the  antiporter. 
This effect could not be attributed to vesicle disruption.  Inactivation  of arginine-oruithine  exchange by pCMBS could 
be reversed  by dithiothreitol.  It was reflected by a decreased  Vm~  x with no change in the K t for arginine  uptake,  and 
correlated  with  a  reduction  of  the  number  of  arginine  binding  sites.  The  poorly  penetrating  p CMBS  had  at  low 
concentrations only access to the reactive SH-group(s)  from the outer surface of the membrane,  while the permeant 
p CMB reacts with SH-group(s) at both membrane surfaces. Arginine and ornithine, if present on the outer surface of 
the  membrane,  protected  the  arginine-ornithine  antiporter  against  p CMBS  inactivation.  Membrane-impermeable 
oxidizing agents have  no effect on the exchange activity,  indicating  that  the antiporter  is not regulated  by the redox 
potential  of  the  environment.  It  is  concluded  that  the  arginine-ornithine  antiporter  contains  one  or  more  reactive 
exofacial SH-groups which are presumably  located in or near the substrate  binding site. 
Introduction 
The arginine-ornithine antiporter is  a  transport  sys- 
tem  that  is  involved  in  the  uptake  and  excretion  of 
metabolites  of  the  arginine  deiminase  pathway  in  a 
variety of lactic acid bacteria [1-7].  The conversion of 
arginine into ornithine by the arginine deiminase path- 
way is coupled to the synthesis of ATP [7-10], and can 
thereby serve as  an additional  source of metabolic en- 
ergy.  Arginine  uptake  mediated  by  this  antiporter  is 
thought to result from a  tight coupling with the down- 
hill  efflux  of  ornithine.  Observations  which  are  con- 
sistent with the operation of this cationic exchanger are: 
(i)  the  demonstration  of  obligatory  coupled  arginine 
and ornithine movements across the cytoplasmic mem- 
brane  which  occur independently of the  protonmotive 
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force,  and  (ii)  both  transportable  substrates  arginine 
and ornithine mutually compete for binding and  trans- 
port [1,6,7].  The exchange beteen arginine and ornithine 
is  electroneutral  and  not  influenced  by  the  electrical 
potential across the membrane (A~k). Kinetic analysis of 
homologous and heterologous exchange modes suggests 
that  the  antiporter  operates  according to  a  Ping-Pong 
mechanism [6]. This model assumes that the binding site 
for the substrate is alternately exposed first at one and 
then at the other surface of the membrane. 
There  is  no  information  available  with  respect  to 
functional  amino  acid  residues  that  are  essential  for 
activity. In this report we describe the effect of various 
sulfhydryl  (SH)-specific  reagents  on  the  arginine- 
ornithine exchange and arginine binding capacity of the 
antiporter in membrane vesicles derived from Lactococ- 
cuslactis.  The results demonstrate that  the SH-reagent 
p-chloromercuribenzene sulfonate, and other mercurials 
inactivate  the  arginine-ornithine  antiporter.  This  in- 
activation is completely reversed by dithiothreitol treat- 
ment.  An  unmodified  SH-residue  is  necessary  for 
arginine binding as demonstrated directly by protection 
and binding experiments. The reactive SH-group is most 
likely located  at  the  outer  surface  of  the  cytoplasmic 
membrane. 
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Methods 
Growth  conditions and isolation  of membrane  oesicles. 
Lactococcus  lactis  ML  3 was  grown  to  late  exponential 
phase  at  30°C  in  a  pH-controlled  (pH  6.4)  5-1  fer- 
menter  on  a  synthetic medium  [2]  supplemented  with 
1% (w/v) galactose and  25  mM L-arginine. Right-side- 
out  membrane vesicles were prepared by osmotic lysis 
[11].  Inside-out  membrane  vesicles  were  obtained  by 
direct lysis of protoplasts by a  single passage through a 
French  pressure  cell  as  described  [6,12].  Membranes 
were stored in liquid nitrogen until use. 
Incubations with redox and sulfhydryl-specific reagents. 
The effect of redox and SH-specific reagents was studied 
by  incubation  of  the  membrane  vesicles  (1.2  mg  of 
protein) at 25 °C with various amounts of reagents in 1 
ml of 50 mM potasisum phosphate (pH  7.0).  After 10 
min, the reaction was arrested by a 40-fold dilution into 
ice-cold 50  mM potassium phosphate (pH 7.0)  supple- 
mented with 500/~M ornithine. Membrane vesicles were 
collected by centrifugation (48 200 X g  for 30 rain, 4 ° C), 
and equilibrated with the dilution buffer for at least 2 h 
at 25 o C. Loaded membranes were concentrated (48 200 
× g  for 30 min, 4 ° C) to a final protein concentration of 
20-25  mg/ml.  In case of cadmium (Cd2+),  potassium 
phosphate  was  replaced  by  50  mM  potassium-Hepes 
(pH 7.0). 
Transport  assays.  For  transport  measurements,  2  ~tl 
of  the  concentrated  membrane  suspension  (usually 
40-50 ~tg of protein) was diluted into 200/~1 of magnet- 
ically  stirred  50  mM  potassium  phosphate  (pH  7.0) 
containing  0.47  /~M  [14C]arginine,  unless  indicated 
otherwise. At times indicated, the reaction was arrested 
by dilution into 2 ml of 0.1  M  LiC1,  and filtration over 
cellulose-nitrate  membrane  filters  (BA  85;  0.45  /~m; 
Schleicher  &  Schuell,  Dassel,  F.R.G.).  Filters  were 
washed  once  with  2  ml  of  0.1  M  LiC1  and  dried. 
Radioactivity  retained  by  the  membrane  filters  was 
corrected for background binding of arginine. Estimates 
of the initial rate were made after 5  s in  triplicate.  All 
transport measurements were performed at 18 ° C. 
For  kinetic  measurements,  external  ornithine  was 
removed by washing  the  loaded  membrane  vesicles  at 
4°C  with  40  ml  of 50  mM  potassium  phosphate  (pH 
7.0). The concentrated membrane suspension was chilled 
on  ice  to  prevent  excessive leak  of ornithine  [6],  and 
used within 1 h. 
Protonmotive-f0rce  driven  uptake  of  leucine  was 
measured as described [13]. 
Arginine  binding  measurements.  Binding  of  arginine 
to membrane vesicles was determined by centrifugation 
as  described  previously  [6].  Membane  vesicles  treated 
and  untreated  with  pCMBS  were  frozen  into  liquid 
nitrogen and subsequently slowly thawed at room tem- 
perature.  This  freeze-thaw cycle was  repeated  twice in 
order to obtain leaky membrane structures which allow 
a  rapid attainment of the arginine binding equilibrium. 
Membranes were washed  and  concentrated (48 000 × g 
for  30  min,  4°C).  Binding  of  [3H]arginine  was  mea- 
sured  in  a  final volume of 0.1  ml  containing  5  mg  of 
membrane vesicle protein suspended into 50 mM potas- 
sium  phosphate  (pH  7.0).  The  [3H]arginine  (37  kBq) 
concentration  was  50  nM.  For  the  estimation  of  the 
apparent dissociation constant (K  d )  and maximal bind- 
ing  level  (Bma~),  the  [3H]arginine  concentration  was 
varied  between  20  nM  and  50  /~M.  The  suspensions 
were equilibrated for 20 rain at 18 ° C, and subsequently 
centrifuged for  10  min in  a  Beckmann Airfuge at  full 
speed. Under these conditions, essentially all membrane 
protein was  found in the pellet.  Samples of 3  times 20 
/~l of the supernatant were taken and counted for radio- 
activity.  Membrane  runs  were  performed  with 
[3H]arginine at a  final concentration of 5 mM,  and the 
amount of label associated with the membrane vesicles 
was taken as non-specific binding [6]. 
Crossed immunoelectrophoresis and localization experi- 
ments.  The  sidedness  of  the  membrane  vesicles  was 
examined  by  localization  experiments  of  the  catalytic 
site of the BFoF1-ATPase using the immunoabsorption 
technique  [14].  Immunoglobulins  were  used  that  were 
raised  against  membrane  vesicles  of  L.  lactis  subsp. 
cremoris  Wg 2  and  showed  a  large  degree  of 
cross-specificity  with  membranes  of  L.  lactis  ML 3. 
Membrane vesicles (5  mg of protein/ml) suspended in 
25  mM  barbital. HC1  (pH  8.0)  were  diluted  with  an 
equal volume of 5% (v/v) Triton X-100 or buffer. The 
suspensions  were incubated  for 1 h  at 25 °C with con- 
stant agitation. For immunoabsorption experiments, im- 
munoglobulins  (about  8  mg  protein)  and  intact  or 
solubilized membrane vesicles (0-0.6  mg protein) were 
mixed  in  25  mM  barbital. HC1  (pH  8.0)  in  a  final 
volume of 0.5 ml. The suspensions were incubated for 1 
h  at  25°C,  and  immunoprecipitates  and  membrane 
fragments  were  removed by  centrifugation  (48 200 × g 
for 30 min,  4 ° C).  Crossed immunoelectrophoresis was 
performed as  described  [15]  with  400  /~l  of the  super- 
natant in the second dimension gel. In the first dimen- 
sion  30  /~g  of  2.5%  (v/v)  Triton  X-100  sohibilized 
membrane  protein  was  applied  to  the  wells.  The  gels 
were run at 3.5 V/cm for 90 min in the first dimension 
and at 1.5 V/cm in the second dimension. After electro- 
phoresis,  immunoprecipitates  were stained  for ATPase 
activity [16].  The BFoF1-ATPase complex forms a char- 
acteristic  immunoprecipitate  in  the  crossed  immunoe- 
lectrophoresis gels. Therefore, Coomassie Brilliant Blue 
staining  [15]  was  used  in most  experiments to identify 
the BFoF1-ATPase complex. The reciprocal area of the 
immunoprecipitate  was  plotted  against  the  amount  of 
membrane vesicles protein used in the immunoabsorp- 
tion  experiment,  and  the  accessibility  of  the  BFoF  l- 
ATPase to  the  antibody from the outer surface of the 
membrane  was  estimated  from  the  relative  slopes  of these  plots  recorded  in  the  presence  and  absence  of 
Triton X-100. 
Other analytical procedures.  The generation  of a  pH 
gradient (ApH, interior acid) upon addition of ATP was 
followed  by  the  fluorescence  quenching  of  9- 
aminoacridine  [17].  The reaction mixture contained (fi- 
nal  concentration):  50  mM  potassium  phosphate  (pH 
7.0),  2  mM  MgSO  4,  100  nM  valinomycin,  5  /zM  9- 
aminoacridine and membrane vesicles (0.2 mg/ml). The 
reaction  was  started  by  the  addition of  5  mM  ATP 
(Mg 2+ salt).  Fluorescence of 9-aminoacridine was mea- 
sured at excitation and emission wavelengths of 405 and 
455  nm, respectively. Since the addition  of ATP causes 
a  decrease in the level of 9-aminoacridine fluorescence, 
a  qualitative  estimate  of  the  pH  gradient  was  made 
upon the addition  of 20 mM NH4C1. A  collapse of the 
pH gradient corresponded to an increase of the level of 
9-aminoacridine fluorescence. 
Protein was determined by the Lowry method [18] in 
the presence of 0.2% (v/v) SDS [19] using bovine serum 
albumin as standard. 
Materials 
L-[U-14C]Arginine  (11  TBq/mol),  L-[2,3,4,5-3H]- 
arginine  (2.4  TBq/mol),  and  L-[U-t4C]leucine  (12.4 
TBq/mol) were obtained from Amersham Corp. (Buck- 
inghamshire,  U.K.)  L-[2,3-3H]Ornithine  (1.1  TBq/ 
mmol) was purchased from New England Nuclear Corp. 
(Boston, MA, U.S.A.).  N-[1-Pyrene]maleimide was from 
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Fluka AG (Buchs,  F.R.G.).  Eosine-5-maleimide, 4-acet- 
amido-4'-maleimidylstilbene-2,2'-disulfonic acid and di- 
dansyl-L-cystine were obtained form Molecular  Probes, 
Inc.  (Eugene,  OR,  U.S.A.).  Phenylarsineoxide,  2-(3,6- 
disulfo-2-hydroxy-l-naphthylazo)benzene  arsonic  acid 
(thorin),  N-[1-naphthyl]maleimide,  NEM,  p-chloro- 
mercuribenzene  sulfonate  (pCMBS),  p-chloromercuri- 
benzoate  (pCMB),  O-(3-hydroxymercuri-2-methoxy- 
propyl)carbamylphenoxyacetate  (mersalyl),  oxidized 
(GSSG) and reduced (GSH) forms of glutathione,  5-hy- 
droxy-2-methyl-l,4-naphthoquinone  (plumbagin),  and 
dithiothreitol  (DTT) were obtained  from Sigma Chem- 
ical Co. (St. Louis, MO, U.S.A.). Solutions of SH-specific 
and  redox  reagents  were  prepared just  before  use  in 
buffer  solutions,  ethanol  or  dimethylformamide.  Final 
solvent  concentations  did  never exceed  1%  (v/v),  and 
appropriate  solvent  controls  were  included  in  the  ex- 
periments.  All  other  chemicals  were  of  reagent  grade 
and acquired  from commercial sources. 
Results 
Effect  of sulfhydryl-group  reagents  on  the  arginine-orni- 
thine antiporter 
The effect of various  SH-modifying reagents  on  the 
activity  of  the  arginine-ornithine  antiporter  was  ex- 
amined in right-side-out membrane vesicles of Lactococ- 
cus lactis.  Membrane vesicles were incubated with these 
compounds at different concentrations and the residual 
arginine-ornithine exchange activity was estimated from 
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Fig. 1. Effect of pCMBS and DTT on the uptake of arginine (A) and efflux of ornithine (B). Membrane vesicles (1.2 mg of protein/ml)  suspended 
in 50 mM potassium phosphate (pH 7.0) were incubated in the absence (open symbols)  or presence (closed symbols) of 100 # M p CMBS for 10 min 
at 25 ° C. Samples of treated and untreated membrane vesicle were diluted 40-fold into an ice-cold solution containing 50 mM potassium phosphate 
(pH 7.0) and 500 #M ornithine. Subsequently, membrane vesicles were washed free of reagent in the presence or absence of 5 mM DTT, and 
equilibrated with 50 mM potassium phosphate (pH 7.0) containing 500 # M L-[2,3-3  H]ornithine. Arginine-ornithine antiport activity (A, by arginine 
uptake; B, by ornithine release) was measured by diluting [3H]ornithine-loaded membrane vesicles 100-fold into 50 mM potassium phosphate (pH 
7.0) containing 25 #M L-[14C]arginine. (A) Uptake of [14C]arginine by untreated (©); DTT-washed (n); pCMBS-treated (O); and pCMBS-treated, 
DTT-washed (I) membrane vesicles. (B) Release of [3H]ornithine by untreated (©); and pCMBS-treated (e) membrane vesicles. Also shown is the 
release of ornithine by untreated (&); and pCMBS-treated (A) membrane vesicles  when diluted into 50 mM potassium phosphate (pH 7.0) in the 
absence of external arginine. 90 
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Fig.  2.  pCMBS,  pCMB and  NEM  inactivation  of arginine-ornithine  exchange in  right-side-out  (A)  and  inside-out  membrane  vesicles (B). 
Membrane vesicles (1.0-1.2 mg of protein/ml) were incubated for 10 min at 25 o C in 50 mM potassium phosphate (pH 7.0) containing increasing 
concentrations  of pCMBS (o),  pCMB (e) and NEM (D), washed free of reagent, and  equilibrated  in 50 mM potassium phosphate  (pH 7.0) 
containing 500/~M ornithine. Arginine uptake by ornithine-loaded membrane vesicles was assayed as described under Materials and Methods, and 
plotted as percentage of the control activity. The control value for arginine uptake by right-side-out and inside-out membrane vesicles were 48 and 
57 pmol/mg of protein per s, respectively. 
the  rate  of arginine  uptake  by  ornithine-loaded  mem- 
brane  vesicles.  Arginine  transport  and  ornithine  efflux 
was  completely  blocked  by  the  mercurials  p-chloro- 
mercuribenzene  sulfonate  (pCMBS)  (Fig.  1A and  2A), 
p-chloromercuribenzoic  acid  (pCMB)  (Fig.  2A),  O- 
(3-hydroxymercuri-2-methoxypropyl)carbamylphenoxy- 
acetate  (mersalyl),  and  HgC12.  IC5o  values  for  the 
inactivation of arginine  transport  are shown in Table I. 
At  pH  8.0,  lipophilic  thiol-specific  alkylating  reagents 
TABLE I 
Half-maximal inhibition ocnstants for sulfhydryl-modifying reagents 
ICso values for  the  inactivation  of arginine-ornithine  exchange by 
various SH-modifying reagents were determined  as described in  the 
legend to Fig. 2. 
Reagent  1C5o  IC5o 
(nmol per mg  (/~M) 
of protein) 
N-Ethylmaleimide  1300 a  1560 
N-[1-Naphthyl]maleimide  290 a  350 
N-[1-Pyrene]maleimide  350 1  420 
Eosine maleimide  200 a.b  _ 
4-Acetamido-4'-maleimidyl- 
stilbene-2,2'-disulfonic acid  500 a,b 
HGC12  9  11 
p CMB  29  35 
p CMBS  14  17 
Mersalyl  22  26 
lodoacetic acid  5 000 b  _ 
Phenylsarsene oxide  350 b  _ 
Cd  2+  1000 b  _ 
Thorin  1500 b  _ 
a  pH 8.0. 
b Less than 10% inhibition at the indicated amount of reagent. 
like  N-ethylmaleimide  (NEM)  (Fig.  1A),  N-[1- 
naphthyl]maleimide  and  N-[1-pyrene]maleimide  dis- 
played a  low reactivity, while the membrane impermea- 
ble  eosine-5-maleimide  and  4-acetamido-4'-maleimi- 
dylstilbene-2,2'-disulfonic acid did not react at all at the 
indicated  concentrations.  The  inactivating  effect  of 
pCMBS  (Fig.  1),  pCMB  and mersalyl (not shown) was 
completely reversed by dithiothreitol  (DTT) and B-mer- 
captoethanol, while these compounds alone were without 
effect, pCMBS (up to 500/~M) had no effect whatsoever 
on the rate of protonmotive-force driven leucine uptake 
(not  shown).  These  results  indicate  that inactivation  of 
the  arginine-ornithine  antiporter  is  due  to  a  specific 
reaction with SH-groups, and not due ,'o the disruption 
of the membrane vesicles. 
Evidence for the presence of vicinal thiol groups in a 
protein can be obtained with the dithiol-specific reagent 
2-(3,6-disulfo-2-hydroxy-l-naphthylazo)benzene  arsonic 
acid (thorin) or the lipophilic phenylarsine oxide [20,21]. 
These compounds may cause the formation of an intra- 
molecular disulfide bridge by the generation of a  cyclic 
dithiol  arsenite.  The stability of this adduct depends on 
the spatial location of the thiols. High concentrations of 
either  of  these  compounds  failed  to  inhibit  arginine- 
ornithine exchange activity (Table I). Cd 2+, a  metal ion 
which is known to bind strongly to dithiols [22] had no 
effect at a  concentration of 2  raM. 
Localization of the reactive sulfhydryl-group 
The  sidedness  of the  interaction  of mercurials  with 
the reactive SH-group(s) was investigated by comparing 
the effects of the permeant  pCMB and poorly permeant 
pCMBS on arginine-ornithine exchange in fight-side-out 1.00 
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Fig.  3.  Accessibility of  the  catalytic  site  of  the  BFoFa-ATPase  in 
right-side-out and inside-out membrane vesicles  to immunoglobulins 
in the absence and presence of Triton X-100. The peak areas in cm  2) 
of  immunoprecipitates of  BFoFI-ATPase activity  after  immunoab- 
sorption of immunoglobulins with  various concentrations of mem- 
brane vesicle  protein were determined as described under Materials 
and  Methods. Absorption experiments were performed with  intact 
(closed symbols) and Triton X-100  solubilized (open symbols) mem- 
brane  vesicles  obtained  by  osmotic  lysis  (11,I2) and  french  press 
treatment (o,o). 
and inside-out membrane vesicles. Inside-out membrane 
vesicles  were obtained after a  single passage of proto- 
plasts  through a  French press.  Immunoabsorption ex- 
periments performed in the presence and absence of the 
detergent Triton  X-100  (Fig.  3)  indicate  that  a  large 
fraction of these membrane vesicles is indeed inside-out 
with respect  to  the accessbility of the catalytic site of 
the  BFoF1-ATPase.  About 77%  of immunoprecipitable 
F1 was exposed  to immunoglobulins from the outside. 
Membrane vesicles obtained by osmotic lysis are mostly 
right-side out. Only 12%  of the F t was accessible  from 
the external surface (Fig. 3). In contrast to right-side-out 
membrane vesicles,  these inside-out membrane vesicles 
generated  a  pH  gradient,  inside  acid,  when  supplied 
with ATP (not shown),  pCMBS is a  poor inhibitor of 
arginine-ornithine  exchange  in  inside-out  membrane 
vesicles (Fig. 2B) compared to right-side-out membrane 
vesicles  (Fig.  2A).  IC5o values  for inactivation of the 
antiporter by pCMBS in inside-out and  right-side-out 
membrane vesicles  were 280  and 14 nmol per mg pro- 
tein, respectively. The permeant pCMB showed similar 
reactivities with inside-out and right-side-out membrane 
vesicles,  with  IC50 values of 55  and  29  nmol per  mg 
protein,  respectively.  These  results  demonstrate  that 
pCMB is  much more reactive in inside-out membrane 
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vesicles than pCMBS (Fig. 2B), whereas little difference 
in reactivity of these organomercurials is observed with 
right-side-out  membrane  vesicles  (Fig.  2A).  We  con- 
clude  that  the  reactive  SH-group(s)  is  exposed  to  the 
external surface of the membrane. 
Effect  of pCMBS  on  the  kinetics  of exchange and  the 
binding of arginine 
The effects of pCMBS on the kinetic parameters of 
arginine-ornithine  exhcange  by  right-side-out  mem- 
brane vesicles  are shown in Table II. When pretreated, 
pCMBS  caused  a  reduction  in  the  maximal  velocity 
(Vm,x) without a major change in the affinity constant 
(Kt) of arginine uptake. Arginine binding can be read- 
ily measured by a  centrifugation assay [6]. In order to 
assess  the effects of pCMBS on the binding of arginine 
to  the  antiporter,  membrane  vesicles  treated  with 
pCMBS  were  subjected  to  three  freeze-thaw cycles  in 
order to increase the accessibility of the substrate bind- 
ing sites. A control sample exhibited the binding (Bma  x) 
of about 70 pmol arginine/mg of protein (Fig. 4) with a 
dissociation constant (Kd)  of 10.5 #M.  Treatment of 
the membrane vesicles with increasing concentrations of 
pCMBS caused a proportional decrease of the binding 
of arginine measured at a concentration of 50 nM. The 
reduction in the number of binding sites correlated with 
the decrease in arginine-ornithine exchange activity (Fig. 
4).  Assuming  a  one-to-one  stoichiometry of  arginine 
binding to the antiporter [6], the data in Fig. 4 suggest 
that the turnover number of the antiporter (Vmax/Bma  x 
ratio) will be  approx.  4-5  s -~.  This value is in agree- 
ment with estimates of the  turnover number reported 
previously [6]. These results indicate that inhibition of 
arginine-ornithine exchange activity by p CMBS is  the 
result of a reduction of the number of active carriers. 
TABLE II 
Effect of pCMBS  on  the kinetic parameters  of arginine-ornithine ex- 
change 
Membrane vesicles were treated with various amounts of pCMBS as 
described in  the  legend  to  Fig.  2.  Kinetic parameters of arginine- 
ornithine exchange were determined by diluting membrane vesicles 
loaded with 200 ~M ornithine 50-fold into 50 mM potassium phos- 
phate (pH  7.0)  containing 0.47  to  10.2 FM [14C]arginine.  Rates of 
arginine uptake were estimated from the amount of label accumulated 
within 5 s. Kinetic data was analyzed by Eady-Hofstee plots. 
Amount of p CMBS  K t  Vm~ 
(nmol per mg  (#M)  (pmol per mg 
of protein)  (of protein per s) 
0  6.2  297 
16  5.9  159 
32  6.3  88 
64  6.9  23 92 
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Fig.  4~  Correlation  between  the  activity  of  the  arginine-ornithine 
antiporter  and  the  number  of  arginine  binding  sites  titrated  with 
pCMBS.  Membrane vesicles were treated with 0, 16, 32, and 64 nmol 
p CMBS/mg of protein, and the binding of L-[2,3,4,5-3 H]arginine was 
measured as described under Materials and methods. The initial free 
arginine concentration was 50 nM. The binding capacity (Bma  x) was 
calculated using the experimentally determined K d  for arginine bind- 
ing of 10.5 btM. It is assumed that the K d  is not affected by pCMBS. 
Bma  x  is  plotted  as  a  function  of  the  maximal  arginine  uptake  rate 
observed  at  each  pCMBS  concentration.  Vm~  x data  shown was  ob- 
tained from Table II. 
External and not internal arginine  protects the arginine- 
ornithine antiporter against pCMBS inactivation 
The effect of the substrates of the antiporter on the 
process  of pCMBS  inactivation was investigated. The 
presence of 1  mM  arginine (Table  III)  at  the time of 
pCMBS treatment largely prevented inactivation of the 
antiporter. The efficiency of protection decreased in the 
following  order:  L-arginine > D-arginine > L-ornithine 
>> L-lysine (not shown). This parallels the specificity of 
transport  [6,7]. No  protection  was  observed  with  L- 
leucine or L-glutamic acid. Protection is not the result of 
complex formation between  pCMBS  and these amino 
acids. When mixed in solution no change in absorbance 
at 250 nm was observed which would otherwise indicate 
the formation of a mercaptide [23]. 
The  sidedness  of  the  protective  effect  of  arginine 
against  pCMBS  inactivation  was  examined  in  more 
detail.  The  effect  of  pCMBS  on  the  activity of  the 
antiporter was studied under three conditions; (i) with 
arginine only present in the external medium; (ii) with 
arginine only present  in  the  intravesicular space;  and 
(iii)  with arginine present  on both  sides  of the  mem- 
brane.  Only  when  the  antiporter  is  saturated  with 
arginine  at  the  external  surface  of  the  membrane,  a 
significant  level  of  protection  of  the  SH-group  is 
observed (Table III). A low level of protection is found 
when arginine is only present at the internal surface of 
the membrane. However, as a result of the loading and 
dilution  procedure,  a  low  concentration  of  arginine 
(about 20/~M) was also present on the external surface 
of the membrane. This amount of arginine almost fully 
accounts  for  the  observed  level  of  protection  with 
arginine only present in the intravesicular space.  These 
results suggest  that the antiporter is only susceptible to 
pCMBS inactivation when the unloaded substrate bind- 
ing site faces the external surface of the membrane. The 
reactive SH-group is presumably located in or near the 
substrate  binding  site  of  the  arginine-ornithine  anti- 
porter. 
Effect  of redox-reagents  on  the  arginine-ornithine  anti- 
porter 
The activity of several transport systems is believed 
to be controlled by the redox state of dithiols in these 
carriers  [24,25]. To  test if the reactive SH-group(s)  of 
the arginine-ornithine antiporter responds to changes in 
the redox potential of the solution, the effect of oxidiz- 
ing  and  reducing  reagents  was  investigated.  Pretreat- 
ment of the membrane vesicles with the membrane-im- 
permeable oxidant ferricyanide (Fe(CN)36  -) (5 mM) led 
to a  reduction of the exchange activity by about  30% 
(not  shown).  Inhibition  appeared  to  be  rather  un- 
specific,  since  a  similar inhibition was  exerted by the 
reductant ferrocyanide (Fe(CN)~-), while the inhibition 
by Fe(CN)36  -  was not relieved by subsequent addition 
of  excess  DTT  (10  mM).  The  disulfide  L-cystine (5 
mM),  its  fluorescent  derivative  didansyl-L-cystine (2 
mM),  and  the  oxidized  form  of  glutathione (GSSG), 
TABLE III 
Substrate protection of the arginine-ornithine antiporter against pCMBS 
inactivation 
Membrane vesicles (10  mg protein/ml)  incubated with or without  1 
mM arginine were diluted 50-fold into a  solution containing 50 mM 
potassium phosphate (pH  7.0),  50  #M  pCMBS  and arginine at  the 
indicated concentration. After 10 min, membranes were diluted 10-fold 
into  50  mM potassium phosphate (pH  7.0),  supplemented with  500 
~tM  ornithine,  washed  once  and  equilibrated  with  the  same buffer. 
The 5  s uptake of arginine was assayed as described under Materials 
and Methods at a  final concentration of 0.47/~M.  Each result is the 
mean of triplicate estimated with indicated + S.E. 
Arginine (mM)  p CMBS 
inside  outside 
Rate of arginine  Protec- 
uptake (pmol per  tion 
mg of protein per s)  (%) 
0  0  -  585-7  - 
0  0  +  55-2  - 
1  1  +  535:5  91 
0  1  +  42 5- 8  70 
1  0.02  +  25 5- 3  38 
0  0.02  +  18 5- 3  25 which react with thiols to form mixed disulfides, had no 
effect when tested up to a concentration of 5 mM (not 
shown).  Similar  results  were  obtained  with  reducing 
reagents  such  as  DTT,  fl-mercaptoethanol, L-cysteine 
and the reduced form of glutathione (GSH). Unlike the 
membrane-impermeable  oxidants,  the  lipophilic  5-hy- 
droxy-2-methyl-l,4-naphthoquinone (plumbagin)  is  a 
very efficient inhibitor of the  antiporter with an  1C5o 
value of about  120  nmol/mg of protein (approx.  150 
/~m).  Inhibition  was  reversed  by  the  addition  of  an 
excess  DTT.  In  the presence of plumbagin, a  marked 
decrease in the rate of protonmotive-force driven leucine 
uptake  was  observed.  However,  qualitative  measure- 
ments of the magnitude of the  imposed  ~b,  using  the 
lipophilic  cation  tetraphenylphosphonium,  indicated 
that plumbagin (when used at  a  concentration of 200 
/xM) has  no  pronounced  effect  on  the  ~b.  Since  the 
arginine-ornithine antiporter is not susceptible to mem- 
brane-impermeable oxidizing reagents,  it  is  concluded 
that the reactive SH-group(s) is not a primary target for 
redox control. 
Discussion 
The results presented in this paper demonstrate that 
sulfhydryl  (SH)-specific  reagents,  in  particular 
organomercurials,  are  effective inhibitors  of  arginine- 
ornithine  exchange.  The  difference  in  the  ability  of 
pCMBS and pCMB to block arginine uptake by fight- 
side-out and inside-out membrane vesicles suggests that 
the  reactive SH-group  of the  antiporter is  exposed  to 
the external surface of the cytoplasmic membrane. The 
finding that pCMBS blocks the binding of arginine to 
the  antiporter,  while  the  presence  of arginine  on  the 
external surface of the membrane alters the reactivity of 
the SH-group towards pCMBS, suggests  that the reac- 
tive SH-group is present near but not necessarily in the 
substrate binding site. It should be realized that inhibi- 
tion  may  be  caused  by  a  substantial  change  in  the 
conformation of the carrier resulting from the reaction 
of the external SH-group(s). This may arise from steric 
hindrance by the mercurial group of substrate binding 
or translocation-related conformational changes. More- 
over, the reaction of pCMBS with the antiporter may 
involve one or more essential SH-groups. 
Care should be taken with respect to the hypothesis 
that the reactive SH-group(s)  plays a  dynamic role in 
the energetics of translocation. Based on the substrate 
protection against NEM inactivation, an active cysteine 
was  postulated  tO  be  involved  in  substrate  or  cation 
binding in  the lactose [26] and proline [27] carrier  of 
Escherichia coli.  Replacement of the critical cysteine by 
oligonucleotide-directed site-specific  mutagenesis by  a 
serine  or  other  amino  acid  residues,  conferred  both 
transport  systems with  a  resistance  against  NEM  in- 
activation without an appreciable effect on the activity 
[28-30].  It was therefore concluded that the NEM-reac- 
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tive cysteine residues in the lactose and proline carrier 
are not important for dynamic events during a translo- 
cation cycle,  but  are located in close proximity to the 
substrate  binding  site.  Our  results  do  not  indicate  a 
definite role of the reactive SH-group in either binding 
of the substrate or the energetics of translocation. 
Evidence has been presented that the activities of the 
lactose and proline carriers in  E.  coli  are controlled by 
the  redox  potential of the  bulk  solution [24,25]. This 
appears  not to be  the case with the arginine-ornithine 
antiporter.  No  significant  effect  on  the  activity  was 
observed  when  the  redox  state  of  the  antiporter  was 
changed with strong oxidizing (Fe(CN) 3-) and reducing 
(DTT)  reagents.  It  furthermore appears  that  the  anti- 
porter is rather insensitive to the oxidation by molecular 
oxygen. 
The lipophilic quinone plumbagin was found to be a 
strong inhibitor. Plumbagin either oxidizes a thiol group 
buried in a more hydrophobic part of the antiporter, or 
reacts with the organomercurial reactive SH-group(s) by 
adduct formation [31]. 
An  interesting observation is  that  the  antiporter is 
relative  insensitive  to  NEM,  while  organomercurials 
readily inhibit exchange activity at low concentrations. 
A  similar  phenomena has  been  noted  with  the  mito- 
chondrial carriers for dicarboxylates, 2-oxoglutarate, and 
neutral amino acids [32]. The 2-oxoglutarate carrier is, 
however,  strongly  inhibited  by  the  fluorescent  mem- 
brane-impermeable eosine-5-maleimide [33], suggesting 
that  eosine  maleimide and  NEM  react  with  different 
SH-groups.  Site-specific  differences between these two 
maleimides  were  also  found  with  the  mitochondrial 
ATP/ADP carrier [34,35]. With respect to the reactivity 
of  cysteine  residues  towards  organomercurials  and 
maleimides, it should be realized that these reagents not 
necessarily react with the same SH-groups [21,23]. It has 
been  suggested  that  the reactivity of cysteine residues 
towards NEM strongly depends on the polarity of the 
environment. For instance, only one out of six cysteine 
residues of the mitochondrial phosphate carrier is reac- 
tive  towards  NEM  when  the  carirer  is  in  its  native 
conformation [36]. The high reactivity of this residue, 
i.e., Cys  42  has been attributed to electrostatic effects of 
two  neighboring  basic  groups,  Lys  41  and  Arg 43  [37]. 
These basic groups would facilitate the dissociation of 
the sulfhydryl-proton, and  therefore increase the reac- 
tivity  of  the  cysteine  with  NEM,  which  involves  the 
addition of the  mercaptide ion  to  the  olefinic double 
bond  of the  maleimide [23,38]. The other cysteine re- 
sidues exist as disulfides or are sterically inaccessible  to 
NEM. 
Numerous  examples  can  be  found  in  literature  in 
which  a  transport  system  is  identified  on  SDS-poly- 
acrylamide  gels  by  the  use  of  a  differential labeling 
method using radioactive NEM [27,39-41].  Membranes 
are  incubated with non-radioactive NEM  in  the  pres- 94 
ence of  a  protective  substrate.  After  removal  of  these 
compounds  the deprotected  carrier  is  allowed  to react 
with only enough radioactive NEM to label specifically 
the protein. A  similar strategy  can be followed with the 
arginine-ornithine antiporter  which can be protected by 
arginine  against  inactivation  by pCMBS.  However,  in 
contrast  to NEM,  mercurials  are  not  suitable  for  this 
procedure,  since  they  tend  to  dissociate  and  associate 
randomly with SH-groups in the sample during electro- 
phoresis [42]. On the other hand,  an  advantage  of the 
inhibitory effect of pCMBS is its potent applicability in 
rapid  sampling  techniques,  using  inhibitor  (pCMBS)- 
stop  experiments  [6]. The  inhibitor  must  be  efficient, 
rapid and block the transport  system without unwanted 
side-effects.  In  this  respect,  some,  but  not  all, 
organomercurials  cause  an  uncoupling of the inwardly 
and  outwardly  directed  solute  flux  mediated  by  the 
mitochondrial  aspartate/glutamate  carrier  [43]. These 
compounds  cause  a  somewhat unspecific  flux  through 
the carrier, that could be reversed by dithiothreitol. This 
weakly specific 'leak' induced by organomercurials was 
not observed with the arginine-ornithine antiporter (see 
Fig. 1B). 
The  interaction  with  organomercurials  can  be  ad- 
vantageous  in  the  purification  of  the  carrier.  Mem- 
branes solubilized with detergent can be passed through 
an organomercurial  agarose  column and the carrier can 
be  eluted  with  DTT  (see  also  Ref.  38).  The  arginine- 
ornithine antiporter  is readily solubilized with  n-octyl- 
fl-D-glucopyranoside  from  a  protein  aggregate  that  is 
obtained after cholate extraction of membrane vesicles 
(Tolner, B.  and Driessen, A.J.M.,  unpublished results). 
When this extract  is passed through  an organomercurial 
agarose  column,  the  arginine-ornithine  antiporter  and 
other proteins stay behind. The antiporter  can be eluted 
by low concentrations of DTT, and resonstituted in an 
active  form  into  proteoliposomes  with  a  specific  ex- 
change  activity  nearly  20-fold  enriched  in  comparison 
to  the  membrane  vesicles.  Only  a  few  protein  bands 
remain  on  a  SDS  polyacrylamide  gel  with  molecular 
masses of 55-64 kDa. A major obstacle we encountered 
with the use of organomercurial agarose columns is the 
great  difference  in  binding  capacity  between  various 
lots of this product. This results  in unwanted variations 
in the degree  of purification. 
Currently,  efforts are made to identify and clone the 
gene coding for the arginine-ornithine antiporter.  Once 
this  goal has been realized,  cysteine residues  are likely 
candidates  for  oligonucleotide-directed  site-specific 
mutagenesis  experiments.  This  should  allow  a  further 
definition  of  the  functional  role  of  these  groups.  In 
conclusion,  our  findings  suggest  that  the  arginine- 
ornithine antiporter  of  Lactococcus  lactis  contains  one 
or more reactive SH-groups  on the external  surface of 
the cytoplasmic membrane which are located in or near 
the substrate  binding site. 
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